Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00167206 · ClinicalTrials.gov registry record · Phase 1
Stem Cell Transplantation for Fanconi Anemia
A Phase 1 study, sponsored by Masonic Cancer Center, University of Minnesota.
- Terminated
- Registry status
- Phase 1
- Development phase
- 16
- Enrollment target
NCT00167206 is a Phase 1 study that was terminated before completion, run by Masonic Cancer Center, University of Minnesota. The registered enrollment target is 16 participants.
The verdict
NCT00167206, a Phase 1 study, was terminated before completion, sponsored by Masonic Cancer Center, University of Minnesota.
- TERMINATED
- Registry status
- Phase 1
- Development phase
- 16 participants
- Enrollment target
Study Summary
The purpose of this study is to determine whether thymic shielding during total body irradiation can be given and whether it will reduce the risk of infections in Fanconi Anemia patients undergoing alternate donor (not a matched sibling) stem cell transplants.
Interventions
- PROCEDURE Total Body Irradiation
- PROCEDURE Hematopoietic Stem Cell Transplant
- PROCEDURE Thymic Shielding During Radiation
- DRUG Cyclophosphamide, Fludarabine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 16 participants |
| Start Date | 2004-03 |
| Est. Completion | 2008-12 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00167206
The ClinicalTrials.gov registry entry for NCT00167206 describes a study currently listed as terminated, categorized as Phase 1. The registered enrollment target is 16 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Masonic Cancer Center, University of Minnesota, which has 249 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 4 interventions - of which Total Body Irradiation is the first listed.
NCT00167206 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00167206 about?
NCT00167206 is a clinical study titled "Stem Cell Transplantation for Fanconi Anemia". The purpose of this study is to determine whether thymic shielding during total body irradiation can be given and whether it will reduce the risk of infections in Fanconi Anemia patients undergoing alternate donor (not a matched sibling) stem cell transplants.
What is the current status of trial NCT00167206?
This trial is currently terminated. It is a Phase 1 study. The enrollment target is 16 participants. The study started on 2004-03. Estimated completion is 2008-12.
What interventions are being tested in trial NCT00167206?
The interventions under investigation include: Total Body Irradiation (PROCEDURE), Hematopoietic Stem Cell Transplant (PROCEDURE), Thymic Shielding During Radiation (PROCEDURE), Cyclophosphamide, Fludarabine (DRUG).
Who is sponsoring clinical trial NCT00167206?
This trial is sponsored by Masonic Cancer Center, University of Minnesota, which has 249 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.